-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the official website of CDE showed that Chengdu Yuandong Biopharmaceutical|Shanxi Pude Pharmaceutical's nicorandil for injection was accepted in imitation 3 categories
.
According to data from Meinenet, in 2020, the sales of nicorandil for terminal injection in China's public medical institutions exceeded the 700 million yuan mark, an increase of more than 50% year-on-year in the first half of this year, and the only manufacturer was Beijing Sihuan Kebao Pharmaceutical
.
Nicorandil cardiovascular system drugs, for the treatment of acute coronary syndrome, angina pectoris, heart failure, unstable angina and the like
.
Sales of nicorandil for terminal injection in China's public medical institutions in recent years (unit: 100 million yuan) Source: Mynet.
com China's public medical institutions' terminal competition pattern.
According to data from Mynet, urban public hospitals, county-level public hospitals, and urban community centers in China in recent years And the sales of nicorandil for terminal injection in township hospitals (Chinese public medical institutions for short) have grown rapidly, breaking the 700 million yuan mark in 2020, and a year-on-year increase of more than 50% in the first half of this year
.
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database The only manufacturer of Nicorandil for injection is Beijing Sihuan Kebao Pharmaceutical, which has not been reviewed yet
.
Prior to this, Yangtze River Pharmaceutical Group | Yangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical and Tianjin Tasly Zhijiao Pharmaceutical had submitted listing applications in the category 3 imitations for review and approval.
After approval, they will be deemed to have been reviewed
.
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database Since this year, Yuandong Bio has 4 products approved for marketing, all of which are approved for production of 4 types of imitations, which are deemed to have been reviewed
.
From the perspective of the therapeutic field (subcategory), it covers antithrombotic drugs, systemic antiviral drugs, and diabetes medications.
Among them, repaglinide-metformin tablets (I) and repaglinide-metformin tablets (II) are the second domestic products.
Home
.
Source: CDE official website, Minet database
.
According to data from Meinenet, in 2020, the sales of nicorandil for terminal injection in China's public medical institutions exceeded the 700 million yuan mark, an increase of more than 50% year-on-year in the first half of this year, and the only manufacturer was Beijing Sihuan Kebao Pharmaceutical
.
Nicorandil cardiovascular system drugs, for the treatment of acute coronary syndrome, angina pectoris, heart failure, unstable angina and the like
.
Sales of nicorandil for terminal injection in China's public medical institutions in recent years (unit: 100 million yuan) Source: Mynet.
com China's public medical institutions' terminal competition pattern.
According to data from Mynet, urban public hospitals, county-level public hospitals, and urban community centers in China in recent years And the sales of nicorandil for terminal injection in township hospitals (Chinese public medical institutions for short) have grown rapidly, breaking the 700 million yuan mark in 2020, and a year-on-year increase of more than 50% in the first half of this year
.
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database The only manufacturer of Nicorandil for injection is Beijing Sihuan Kebao Pharmaceutical, which has not been reviewed yet
.
Prior to this, Yangtze River Pharmaceutical Group | Yangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical and Tianjin Tasly Zhijiao Pharmaceutical had submitted listing applications in the category 3 imitations for review and approval.
After approval, they will be deemed to have been reviewed
.
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database Since this year, Yuandong Bio has 4 products approved for marketing, all of which are approved for production of 4 types of imitations, which are deemed to have been reviewed
.
From the perspective of the therapeutic field (subcategory), it covers antithrombotic drugs, systemic antiviral drugs, and diabetes medications.
Among them, repaglinide-metformin tablets (I) and repaglinide-metformin tablets (II) are the second domestic products.
Home
.
Source: CDE official website, Minet database
![benzyl N-{2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethyl}carbamate](https://file.echemi.com/fileManage/upload/goodpicture/20210823/m20210823171124543.jpg)
